Literature DB >> 2828430

Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.

R S Ross1, R E Gregg, S W Law, J C Monge, S M Grant, K Higuchi, T J Triche, J Jefferson, H B Brewer.   

Abstract

apoB DNA, RNA, and protein from two patients with homozygous hypobetalipoproteinemia (HBL) were evaluated and compared with normal individuals. Southern blot analysis with 10 different cDNA probes revealed a normal gene without major insertions, deletions, or rearrangements. Northern and slot blot analyses of total liver mRNA from HBL patients documented a normal size apoB mRNA that was present in greatly reduced quantities. ApoB protein was detected within HBL hepatocytes utilizing immunohistochemical techniques; however, it was markedly reduced in quantity when compared with control samples. No apoB was detectable in the plasma of HBL individuals with an ELISA assay. These data are most consistent with a mutation in the coding portion of the apoB gene in HBL patients, leading to an abnormal apoB protein and apoB mRNA instability. These results are distinct from those previously noted in abetalipoproteinemia, which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828430      PMCID: PMC329607          DOI: 10.1172/JCI113357

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC.

Authors:  S H Orkin; S E Antonarakis; H H Kazazian
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

Review 2.  Hybridization of nucleic acids immobilized on solid supports.

Authors:  J Meinkoth; G Wahl
Journal:  Anal Biochem       Date:  1984-05-01       Impact factor: 3.365

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  RNA processing errors in patients with beta-thalassemia.

Authors:  T J Ley; N P Anagnou; G Pepe; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

5.  Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia.

Authors:  D P Muller; J K Lloyd
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Alpha-thalassaemia caused by a polyadenylation signal mutation.

Authors:  D R Higgs; S E Goodbourn; J Lamb; J B Clegg; D J Weatherall; N J Proudfoot
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

7.  beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site.

Authors:  S E Antonarakis; S H Irkin; T C Cheng; A F Scott; J P Sexton; S P Trusko; S Charache; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.

Authors:  S W Law; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.

Authors:  S W Law; G Gray; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

10.  ATA box transcription mutation in beta-thalassemia.

Authors:  S H Orkin; J P Sexton; T C Cheng; S C Goff; P J Giardina; J I Lee; H H Kazazian
Journal:  Nucleic Acids Res       Date:  1983-07-25       Impact factor: 16.971

View more
  9 in total

1.  Unusual presentation of three siblings with familial heterozygous hypobetalipoproteinaemia.

Authors:  V Kairamkonda; M Dalzell
Journal:  Eur J Pediatr       Date:  2003-01-11       Impact factor: 3.183

2.  Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred.

Authors:  M Leppert; J L Breslow; L Wu; S Hasstedt; P O'Connell; M Lathrop; R R Williams; R White; J M Lalouel
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

Authors:  P J Talmud; J K Lloyd; D P Muller; D R Collins; J Scott; S Humphries
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Liver fibrosis in a patient with familial homozygous hypobetalipoproteinaemia: possible role of vitamin supplementation.

Authors:  J Y Scoazec; M E Bouma; J F Roche; D Blache; N Verthier; G Feldmann; G Gay
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

Authors:  D R Collins; T J Knott; R J Pease; L M Powell; S C Wallis; S Robertson; C R Pullinger; R W Milne; Y L Marcel; S E Humphries
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

Review 7.  Apolipoproteins in vascular biology and atherosclerotic disease.

Authors:  Anurag Mehta; Michael D Shapiro
Journal:  Nat Rev Cardiol       Date:  2021-10-08       Impact factor: 32.419

8.  Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency.

Authors:  S S Fojo; U Beisiegel; U Beil; K Higuchi; M Bojanovski; R E Gregg; H Greten; H B Brewer
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 9.  Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis.

Authors:  Katie M Lebold; Maret G Traber
Journal:  Free Radic Biol Med       Date:  2013-08-03       Impact factor: 7.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.